Dispatch Biotherapeutics
Business Services · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
25 N 38th St Ste 600, Philadelphia, Penn...Website
www.dispatchbio.comRevenue
$15.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Dispatch Biotherapeutics
Dispatch Biotherapeutics is a biotechnology company pioneering universal immunotherapies for solid tumors using their innovative Flare platform, aiming to enhance immune targeting and overcome tumor resistance for improved cancer treatment.Explore more
Dispatch Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dispatch Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Dispatch Biotherapeutics launches new products
Funding: Get notified immidiatlly once Dispatch Biotherapeutics has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Dispatch Biotherapeutics had a recent Job posting/layoffs
Dispatch Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Dispatch Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Dispatch Biotherapeutics
Check out if Dispatch Biotherapeutics is spiking on competitors!
Earning: See what the market has to say on Dispatch Biotherapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Dispatch Biotherapeutics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Dispatch Biotherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Dispatch Biotherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Dispatch Biotherapeutics.
Dispatch Biotherapeutics financials insights
Gather financial insights about Dispatch Biotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$216M
Dispatch Biotherapeutics Tech Stack
A closer look at the technologies used by Dispatch Biotherapeutics
Most Recent Scoops
Open Position
Hiring Plans
Dispatch Biotherapeutics is hiring in Legal for the first time in 12 months.
Hiring Plans
Open Position
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Dispatch Biotherapeutics News & Media
CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
SHANGHAI, PHILADELPHIA and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, and Dispatch Bio, a biotech company engineering a universal treatment across solid tumors...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Dispatch Biotherapeutics
Sign Up For FreeTo access detailed company insights
Dispatch Biotherapeutics is a biotechnology company pioneering universal immunotherapies for solid tumors using their innovative Flare platform, aiming to enhance immune targeting and overcome tumor resistance for improved cancer treatment.... Read More
